Patent · US Active

Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer

US10004730B2 · kind B2 · utility

0Cited by

7References

30Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Zhou Wang · Aachen, DE
Joel B. Nelson · Pittsburgh, US
Minh B. Nguyen · Thousand Oaks, US
John S. Lazo · Charlottesville, US
Paul A. Johnston · Hawthorne, US
Peter Wipf · Pittsburgh, US

Key dates

Filing date	Mar 13, 2017
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Mar 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treating prostate cancer in a subject, comprising administering a therapeutically effective amount of at least one agent to the subject, wherein the agent is selected from:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.